Mark Jeffrey DeLong, Chief Business & Strat Officer: Apellis Pharmaceuticals APLS Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $42,480.28
Shares · price: 1,396 sh · $30.43 a share
Held after: 84,673 sh
Stock: Apellis Pharmaceuticals APLS
Person: Mark Jeffrey DeLongChief Business & Strat Officer
Trade date: 25/01/22
Filed: 25/01/23
Days to filing: 1 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/23~25/02/21

Mark Jeffrey DeLong's recent trades

Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$8,151
368 sh
$8,151
Filed 02/13
Traded 02/11
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$73.4K
3,371 sh
$73.4K
Filed 01/23
Traded 01/22
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$26.4K
1,334 sh
$26.4K
Filed 01/21
Traded 01/20
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$39.5K
1,780 sh
$39.5K
Filed 01/15
Traded 01/13
Mark Jeffrey DeLongChief Business & Strat Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$10.4K
363 sh
$10.4K
Filed 25/02/12
Traded 25/02/11